Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Organ-on-chip technologies: Novel tools with the potential to revolutionize osteoarthritis research and clinical development

Paggi CA.

Narrative Review on Osteoarthritis, published in Osteoarthr Cartil Open (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Osteoarthr Cartil Open (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41078569
PMCID
PMC12510194
DOI
10.1016/j.ocarto.2025.100686

Abstract (original English)

Objective To critically evaluate the evolution of in vitro models for osteoarthritis (OA) research, with a specific focus on organ-on-chip (OOC) technologies, and to discuss their potential to overcome the limitations of traditional 2D, 3D, and explant models in disease modelling, drug discovery, and preclinical toxicology. Methods This review synthesizes findings from recent literature regarding historical and current in vitro platforms used in OA research. It categorizes models based on biological complexity and physiological relevance, with particular emphasis on biomechanical and biochemical stimulation in OOC systems. Key examples from the literature are discussed to illustrate the utility and scalability of emerging platforms. Results Traditional 2D cultures, while widely used, lack the spatial and environmental complexity necessary to replicate native joint physiology. 3D cultures and explant models provide improved architecture and cellular context, but face challenges related to standardization, longevity, and reproducibility. OOC systems offer a dynamic and tunable microenvironment that supports real-time monitoring and integration of mechanical cues such as shear stress and compression. These platforms have been successfully employed to investigate immune cell migration, drug permeability across barriers, and cytokine-induced matrix degradation. Furthermore, their ap

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research